# SolarWindow Technologies, Inc.: financial statements, quarterly

WNDW · OTC · CIK 1071840 · [Materials](/sectors/materials.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/wndw.md) · [Financials](/companies/wndw/financials.md) · [Filings](/companies/wndw/filings.md) · [Insiders](/companies/wndw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wndw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0 d](/filings/0001171843-24-006491.md) | not reported | not reported | [0.0](/filings/0001171843-24-003957.md) | [0.0 d](/filings/0001171843-24-006491.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | [172 d](/filings/0001171843-24-006491.md) | [117](/filings/0001171843-25-000250.md) | [133](/filings/0001171843-25-002157.md) | [162](/filings/0001171843-25-004429.md) | [183 d](/filings/0001171843-25-007295.md) | [137](/filings/0001171843-26-000166.md) | [173](/filings/0001171843-26-002353.md) | [168](/filings/0001171843-26-004600.md) | [144 d](/filings/0001171843-25-007295.md) | [149](/filings/0001171843-26-000166.md) | [171](/filings/0001171843-26-002353.md) | [174](/filings/0001171843-26-004600.md) |
| Selling, general and administrative | $k | [419 d](/filings/0001171843-24-006491.md) | [452](/filings/0001171843-25-000250.md) | [369](/filings/0001171843-25-002157.md) | [693](/filings/0001171843-25-004429.md) | [498 d](/filings/0001171843-25-007295.md) | [458](/filings/0001171843-26-000166.md) | [496](/filings/0001171843-26-002353.md) | [386](/filings/0001171843-26-004600.md) | [394 d](/filings/0001171843-25-007295.md) | [464](/filings/0001171843-26-000166.md) | [453](/filings/0001171843-26-002353.md) | [553](/filings/0001171843-26-004600.md) |
| Operating income | $k | [(591) d](/filings/0001171843-24-006491.md) | [(568)](/filings/0001171843-25-000250.md) | [(502)](/filings/0001171843-25-002157.md) | [(855)](/filings/0001171843-25-004429.md) | [(680) d](/filings/0001171843-25-007295.md) | [(595)](/filings/0001171843-26-000166.md) | [(669)](/filings/0001171843-26-002353.md) | [(554)](/filings/0001171843-26-004600.md) | [(538) d](/filings/0001171843-25-007295.md) | [(613)](/filings/0001171843-26-000166.md) | [(624)](/filings/0001171843-26-002353.md) | [(727)](/filings/0001171843-26-004600.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(588) d](/filings/0001171843-24-006491.md) | [(501)](/filings/0001171843-25-000250.md) | [(847)](/filings/0001171843-25-002157.md) | [(1,462)](/filings/0001171843-25-004429.md) | [(645) d](/filings/0001171843-25-007295.md) | [(552)](/filings/0001171843-26-000166.md) | [(654)](/filings/0001171843-26-002353.md) | [(546)](/filings/0001171843-26-004600.md) | [(505) d](/filings/0001171843-25-007295.md) | [(571)](/filings/0001171843-26-000166.md) | [(589)](/filings/0001171843-26-002353.md) | [(696)](/filings/0001171843-26-004600.md) |
| Diluted EPS | $ per share | not reported | [(0.01)](/filings/0001171843-25-000250.md) | [(0.02)](/filings/0001171843-25-002157.md) | [(0.03)](/filings/0001171843-25-004429.md) | not reported | [(0.01)](/filings/0001171843-26-000166.md) | [(0.01)](/filings/0001171843-26-002353.md) | [(0.01)](/filings/0001171843-26-004600.md) | not reported | [(0.01)](/filings/0001171843-26-000166.md) | [(0.01)](/filings/0001171843-26-002353.md) | [(0.01)](/filings/0001171843-26-004600.md) |
| Basic EPS | $ per share | not reported | [(0.01)](/filings/0001171843-25-000250.md) | [(0.02)](/filings/0001171843-25-002157.md) | [(0.03)](/filings/0001171843-25-004429.md) | not reported | [(0.01)](/filings/0001171843-26-000166.md) | [(0.01)](/filings/0001171843-26-002353.md) | [(0.01)](/filings/0001171843-26-004600.md) | not reported | [(0.01)](/filings/0001171843-26-000166.md) | [(0.01)](/filings/0001171843-26-002353.md) | [(0.01)](/filings/0001171843-26-004600.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [493](/filings/0001171843-24-001989.md) | [135](/filings/0001171843-24-000236.md) | [1,199](/filings/0001171843-24-001989.md) | [841](/filings/0001171843-24-003957.md) | [1,249](/filings/0001171843-25-007295.md) | [722](/filings/0001171843-25-000250.md) | [3,798](/filings/0001171843-25-002157.md) | [3,238](/filings/0001171843-25-004429.md) | [6,556](/filings/0001171843-26-002353.md) | [5,898](/filings/0001171843-26-000166.md) | [5,392](/filings/0001171843-26-002353.md) | [4,789](/filings/0001171843-26-004600.md) |
| Current assets | $k | [6,304](/filings/0001171843-24-006491.md) | [5,873](/filings/0001171843-24-000236.md) | [5,372](/filings/0001171843-24-001989.md) | [5,621](/filings/0001171843-24-003957.md) | [4,990](/filings/0001171843-25-007295.md) | [4,532](/filings/0001171843-25-000250.md) | [3,931](/filings/0001171843-25-002157.md) | [3,409](/filings/0001171843-25-004429.md) | [6,602](/filings/0001171843-26-004600.md) | [6,056](/filings/0001171843-26-000166.md) | [5,505](/filings/0001171843-26-002353.md) | [4,840](/filings/0001171843-26-004600.md) |
| Total assets | $k | [7,620](/filings/0001171843-24-006491.md) | [7,184](/filings/0001171843-24-000236.md) | [6,683](/filings/0001171843-24-001989.md) | [5,637](/filings/0001171843-24-003957.md) | [5,004](/filings/0001171843-25-007295.md) | [4,544](/filings/0001171843-25-000250.md) | [3,941](/filings/0001171843-25-002157.md) | [3,425](/filings/0001171843-25-004429.md) | [6,645](/filings/0001171843-26-004600.md) | [6,125](/filings/0001171843-26-000166.md) | [5,569](/filings/0001171843-26-002353.md) | [4,901](/filings/0001171843-26-004600.md) |
| Current liabilities | $k | [287](/filings/0001171843-24-006491.md) | [332](/filings/0001171843-24-000236.md) | [226](/filings/0001171843-24-001989.md) | [359](/filings/0001171843-24-003957.md) | [322](/filings/0001171843-25-007295.md) | [360](/filings/0001171843-25-000250.md) | [358](/filings/0001171843-25-002157.md) | [391](/filings/0001171843-25-004429.md) | [194](/filings/0001171843-26-004600.md) | [245](/filings/0001171843-26-000166.md) | [278](/filings/0001171843-26-002353.md) | [306](/filings/0001171843-26-004600.md) |
| Total liabilities | $k | [287](/filings/0001171843-24-006491.md) | [332](/filings/0001171843-24-000236.md) | [226](/filings/0001171843-24-001989.md) | [359](/filings/0001171843-24-003957.md) | [322](/filings/0001171843-25-007295.md) | [360](/filings/0001171843-25-000250.md) | [358](/filings/0001171843-25-002157.md) | [391](/filings/0001171843-25-004429.md) | [194](/filings/0001171843-26-004600.md) | [245](/filings/0001171843-26-000166.md) | [278](/filings/0001171843-26-002353.md) | [306](/filings/0001171843-26-004600.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [7,333](/filings/0001171843-25-007295.md) | [6,853](/filings/0001171843-25-004429.md) | [6,457](/filings/0001171843-25-004429.md) | [5,277](/filings/0001171843-25-004429.md) | [4,682](/filings/0001171843-26-004600.md) | [4,184](/filings/0001171843-26-004600.md) | [3,584](/filings/0001171843-26-004600.md) | [3,034](/filings/0001171843-26-004600.md) | [6,451](/filings/0001171843-26-004600.md) | [5,880](/filings/0001171843-26-004600.md) | [5,291](/filings/0001171843-26-004600.md) | [4,594](/filings/0001171843-26-004600.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(501) d](/filings/0001171843-24-006491.md) | [(558)](/filings/0001171843-25-000250.md) | [(234) d](/filings/0001171843-25-002157.md) | [(358) d](/filings/0001171843-25-004429.md) | [(592) d](/filings/0001171843-25-007295.md) | [(528)](/filings/0001171843-26-000166.md) | [75.6 d](/filings/0001171843-26-002353.md) | [(552) d](/filings/0001171843-26-004600.md) | [(499) d](/filings/0001171843-25-007295.md) | [(628)](/filings/0001171843-26-000166.md) | [(506) d](/filings/0001171843-26-002353.md) | [(601) d](/filings/0001171843-26-004600.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001171843-24-006491.md) | not reported | not reported | [0.0 d](/filings/0001171843-24-003957.md) | [0.0 d](/filings/0001171843-25-007295.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [53.2](/filings/0001171843-24-000236.md) | [53.2](/filings/0001171843-24-001989.md) | [53.2](/filings/0001171843-24-003957.md) | [53.2](/filings/0001171843-25-000250.md) | [53.2](/filings/0001171843-25-002157.md) | [53.2](/filings/0001171843-25-004429.md) | [53.2](/filings/0001171843-26-000166.md) | [53.2](/filings/0001171843-26-002353.md) | [53.2](/filings/0001171843-26-004600.md) | [65.8](/filings/0001171843-26-000166.md) | [65.8](/filings/0001171843-26-002353.md) | [65.8](/filings/0001171843-26-004600.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,779,045 at 2026-07-10, from the cover of the [10-Q filed 2026-07-13](/filings/0001171843-26-004600.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.